Literature DB >> 11513915

Telomere shortening in atherosclerosis.

N J Samani, R Boultby, R Butler, J R Thompson, A H Goodall.   

Abstract

Eukaryotic chromosomes end with telomeres, which shorten with cellular ageing. We investigated whether atherosclerosis is associated with systemic evidence of accelerated cellular ageing. We compared mean length of terminal restriction fragments (TRF), a measure of average telomere size, in leucocyte DNA of ten patients with severe coronary artery disease (CAD) with that of 20 controls without CAD. Adjusting for age and sex, cases had mean TRF lengths of 303 (SD 90) base pairs shorter than those of controls (p=0.002)-ie, equivalent in size to individuals with no CAD who are 8.6 years older. Although this is a pilot study, the findings could be relevant to the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Year:  2001        PMID: 11513915     DOI: 10.1016/S0140-6736(01)05633-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  184 in total

Review 1.  Telomeres and telomerase in the fetal origins of cardiovascular disease: a review.

Authors:  Ellen W Demerath; Noel Cameron; Matthew W Gillman; Bradford Towne; Roger M Siervogel
Journal:  Hum Biol       Date:  2004-02       Impact factor: 0.553

2.  Plant telomere biology.

Authors:  Thomas D McKnight; Dorothy E Shippen
Journal:  Plant Cell       Date:  2004-04       Impact factor: 11.277

3.  Leukocyte telomere length is associated with noninvasively measured age-related disease: The Cardiovascular Health Study.

Authors:  Jason L Sanders; Annette L Fitzpatrick; Robert M Boudreau; Alice M Arnold; Abraham Aviv; Masayuki Kimura; Linda F Fried; Tamara B Harris; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-09-20       Impact factor: 6.053

4.  The end is nigh.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2010-08       Impact factor: 4.599

Review 5.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

6.  Increased placental telomerase mRNA in hypertensive disorders of pregnancy.

Authors:  Ossie Geifman-Holtzman; Yali Xiong; Eliezer J Holtzman; Barbara Hoffman; John Gaughan; Dan A Liebermann
Journal:  Hypertens Pregnancy       Date:  2010       Impact factor: 2.108

7.  Human skeletal muscle feed arteries: evidence of regulatory potential.

Authors:  S J Ives; R H I Andtbacka; S-Y Park; A J Donato; J R Gifford; R D Noyes; L A Lesniewski; R S Richardson
Journal:  Acta Physiol (Oxf)       Date:  2012-08-06       Impact factor: 6.311

Review 8.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.

Authors:  Karima Ait-Aissa; Johnathan D Ebben; Andrew O Kadlec; Andreas M Beyer
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

9.  Telomere length in patients with systemic lupus erythematosus and its associations with carotid plaque.

Authors:  Carly Skamra; Juanita Romero-Diaz; Alexander Sandhu; QiQuan Huang; Jungwha Lee; William Pearce; David D McPherson; Kim Sutton-Tyrrell; Richard Pope; Rosalind Ramsey-Goldman
Journal:  Rheumatology (Oxford)       Date:  2013-02-04       Impact factor: 7.580

10.  Associations between circulating sex steroid hormones and leukocyte telomere length in men in the National Health and Nutrition Examination Survey.

Authors:  S B Coburn; B I Graubard; B Trabert; K A McGlynn; M B Cook
Journal:  Andrology       Date:  2018-05-11       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.